论文信息 - Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma. - 字舞流文

Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma.

W. Stadler | N. Vogelzang | M. Mahowald | T. Gajewski | M. Markiewicz | M. Aklilu | M. Johnson